People News

Share this article:

Oriel Therapeutics, a specialty pharma concentrated on respiratory care, has appointed Richard Fuller as CEO, effective immediately. Fuller was formerly a senior executive at GlaxoSmithKline, and was most recently executive vice president of research and development at Aerovance.

 
TheraGenetics Limited, a personalized medicine diagnostics company, has appointed Robert McBurney to executive vice president.  McBurney will report to Richard Kivel, CEO of TheraGenetics.

 
Curemark, a biotech focused on the treatment of neurological and other diseases, has appointed Elisa Zinberg as vice president of operations. Zinberg was previously COO of The Masters Circle, a health care consulting company.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters